Unite Us vs Pfizer

Side-by-side comparison of AI visibility scores, market position, and capabilities

Pfizer leads in AI visibility (93 vs 72)
Unite Us logo

Unite Us

LeaderHealthcare

Social Care Coordination & Health Equity

Unite Us is the leading social care coordination platform connecting health systems, government, and CBOs; facilitated 60M+ care connections; raised $150M Series C; key partner for Medicaid 1115 waiver states.

AI VisibilityBeta
Overall Score
B72
Category Rank
#107 of 596
AI Consensus
83%
Trend
stable
Per Platform
ChatGPT
77
Perplexity
74
Gemini
71

About

Unite Us is a New York-based health technology company that operates the country''s leading social care coordination network. Founded in 2013 by veterans seeking better connections to community resources, Unite Us has built a platform that enables healthcare organizations, government agencies, and community-based organizations (CBOs) to coordinate referrals, track outcomes, and share data across the full spectrum of social determinants of health — including housing, food access, transportation, employment, and mental health services. The platform provides secure referral routing, outcome tracking, payments infrastructure, and population-level analytics to its network of partners.

Full profile
Pfizer logo

Pfizer

LeaderHealthcare Tech

Enterprise

Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.

AI VisibilityBeta
Overall Score
A93
Category Rank
#1 of 596
AI Consensus
80%
Trend
stable
Per Platform
ChatGPT
94
Perplexity
89
Gemini
94

About

Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.

Full profile

AI Visibility Head-to-Head

72
Overall Score
93
#107
Category Rank
#1
83
AI Consensus
80
stable
Trend
stable
77
ChatGPT
94
74
Perplexity
89
71
Gemini
94
77
Claude
92
72
Grok
98

Key Details

Category
Social Care Coordination & Health Equity
Enterprise
Tier
Leader
Leader
Entity Type
brand
company

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.